Software - Application
Compare Stocks
5 / 10Stock Comparison
AMODW vs PRZO vs RCAT vs AEYE vs AVAV
Revenue, margins, valuation, and 5-year total return — side by side.
Aerospace & Defense
Computer Hardware
Software - Application
Aerospace & Defense
AMODW vs PRZO vs RCAT vs AEYE vs AVAV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Aerospace & Defense | Computer Hardware | Software - Application | Aerospace & Defense |
| Market Cap | $862K | $8M | $1.03B | $98M | $8.40B |
| Revenue (TTM) | $0.00 | $858K | $26M | $40M | $1.61B |
| Net Income (TTM) | $-8M | $-9M | $-59M | $-3M | $-224M |
| Gross Margin | — | -9.9% | 7.9% | 78.3% | 21.8% |
| Operating Margin | — | -7.3% | -234.6% | -7.9% | -8.3% |
| Forward P/E | 0.2x | — | 94.3x | — | 58.4x |
| Total Debt | $4M | $419K | $18M | $721K | $64M |
| Cash & Equiv. | $736K | $4M | $168M | $5M | $41M |
AMODW vs PRZO vs RCAT vs AEYE vs AVAV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 24 | May 26 | Return |
|---|---|---|---|
| Alpha Modus Holding… (AMODW) | 100 | 31.5 | -68.5% |
| ParaZero Technologi… (PRZO) | 100 | 36.3 | -63.7% |
| Red Cat Holdings, I… (RCAT) | 100 | 91.2 | -8.8% |
| AudioEye, Inc. (AEYE) | 100 | 47.1 | -52.9% |
| AeroVironment, Inc. (AVAV) | 100 | 126.7 | +26.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMODW vs PRZO vs RCAT vs AEYE vs AVAV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMODW ranks third and is worth considering specifically for value.
- Lower P/E (0.2x vs 58.4x)
Among these 5 stocks, PRZO doesn't own a clear edge in any measured category.
RCAT has the current edge in this matchup, primarily because of its strength in growth exposure.
- Rev growth 459.8%, EPS growth 29.4%, 3Y rev CAGR 106.6%
- 459.8% revenue growth vs AMODW's -15.8%
- +81.9% vs AMODW's -66.4%
AEYE is the clearest fit if your priority is quality.
- -7.6% margin vs PRZO's -10.8%
AVAV is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- beta 1.55
- 498.7% 10Y total return vs AEYE's 96.5%
- Lower volatility, beta 1.55, Low D/E 7.3%, current ratio 3.52x
- Beta 1.55, current ratio 3.52x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 459.8% revenue growth vs AMODW's -15.8% | |
| Value | Lower P/E (0.2x vs 58.4x) | |
| Quality / Margins | -7.6% margin vs PRZO's -10.8% | |
| Stability / Safety | Beta 1.55 vs RCAT's 3.09, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +81.9% vs AMODW's -66.4% | |
| Efficiency (ROA) | -5.0% ROA vs AMODW's -18.8% |
AMODW vs PRZO vs RCAT vs AEYE vs AVAV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
AMODW vs PRZO vs RCAT vs AEYE vs AVAV — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AEYE leads in 2 of 6 categories
AVAV leads 1 • RCAT leads 1 • AMODW leads 0 • PRZO leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AEYE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVAV and AMODW operate at a comparable scale, with $1.6B and $0 in trailing revenue. Profitability is closely matched — net margins range from -7.6% (AEYE) to -10.8% (PRZO). On growth, AVAV holds the edge at +143.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $857,883 | $26M | $40M | $1.6B |
| EBITDAEarnings before interest/tax | -$4M | -$6M | -$58M | -$504,000 | $82M |
| Net IncomeAfter-tax profit | -$8M | -$9M | -$59M | -$3M | -$224M |
| Free Cash FlowCash after capex | -$2M | -$5M | -$75M | $2M | -$183M |
| Gross MarginGross profit ÷ Revenue | — | -9.9% | +7.9% | +78.3% | +21.8% |
| Operating MarginEBIT ÷ Revenue | — | -7.3% | -2.3% | -7.9% | -8.3% |
| Net MarginNet income ÷ Revenue | — | -10.8% | -2.3% | -7.6% | -13.9% |
| FCF MarginFCF ÷ Revenue | — | -6.2% | -2.9% | +5.5% | -11.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +26.6% | — | +7.9% | +143.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -176.2% | -43.1% | — | +29.0% | -51.5% |
Valuation Metrics
AEYE leads this category, winning 2 of 5 comparable metrics.
Valuation Metrics
At 0.2x trailing earnings, AMODW trades at a 100% valuation discount to AVAV's 108.6x P/E. On an enterprise value basis, AMODW's 0.9x EV/EBITDA is more attractive than AVAV's 103.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $862,310 | $8M | $1.0B | $98M | $8.4B |
| Enterprise ValueMkt cap + debt − cash | $4M | $4M | $876M | $93M | $8.4B |
| Trailing P/EPrice ÷ TTM EPS | 0.21x | -0.64x | -17.28x | -31.44x | 108.57x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 94.27x | — | 58.45x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 0.88x | — | — | — | 103.03x |
| Price / SalesMarket cap ÷ Revenue | — | 8.75x | 25.17x | 2.42x | 10.24x |
| Price / BookPrice ÷ Book value/share | — | — | 5.04x | 20.31x | 5.35x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — | — |
Profitability & Efficiency
AVAV leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
AVAV delivers a -6.4% return on equity — every $100 of shareholder capital generates $-6 in annual profit, vs $-3 for PRZO. AVAV carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to AEYE's 0.15x. On the Piotroski fundamental quality scale (0–9), AMODW scores 4/9 vs PRZO's 2/9, reflecting mixed financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | -2.6% | -33.6% | -47.8% | -6.4% |
| ROA (TTM)Return on assets | -18.8% | -146.0% | -28.8% | -9.5% | -5.0% |
| ROICReturn on invested capital | — | — | -71.0% | -42.4% | +3.6% |
| ROCEReturn on capital employed | — | -92.1% | -42.9% | -17.7% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 2 | 4 | 4 | 3 |
| Debt / EquityFinancial leverage | — | — | 0.07x | 0.15x | 0.07x |
| Net DebtTotal debt minus cash | $3M | -$4M | -$149M | -$5M | $23M |
| Cash & Equiv.Liquid assets | $735,814 | $4M | $168M | $5M | $41M |
| Total DebtShort + long-term debt | $4M | $419,480 | $18M | $721,000 | $64M |
| Interest CoverageEBIT ÷ Interest expense | -1.15x | — | — | -2.79x | -5.99x |
Total Returns (Dividends Reinvested)
RCAT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RCAT five years ago would be worth $26,865 today (with dividends reinvested), compared to $1,767 for PRZO. Over the past 12 months, RCAT leads with a +81.9% total return vs AMODW's -66.4%. The 3-year compound annual growth rate (CAGR) favors RCAT at 125.6% vs PRZO's -43.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -51.2% | -46.1% | +13.2% | -21.0% | -34.3% |
| 1-Year ReturnPast 12 months | -66.4% | -30.2% | +81.9% | -34.1% | -0.1% |
| 3-Year ReturnCumulative with dividends | -64.3% | -82.3% | +1048.4% | +17.1% | +63.2% |
| 5-Year ReturnCumulative with dividends | -64.3% | -82.3% | +168.7% | -57.7% | +63.2% |
| 10-Year ReturnCumulative with dividends | -64.3% | -82.3% | -97.8% | +96.5% | +498.7% |
| CAGR (3Y)Annualised 3-year return | -29.0% | -43.9% | +125.6% | +5.4% | +17.7% |
Risk & Volatility
Evenly matched — RCAT and AVAV each lead in 1 of 2 comparable metrics.
Risk & Volatility
AVAV is the less volatile stock with a 1.55 beta — it tends to amplify market swings less than RCAT's 3.09 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RCAT currently trades 55.2% from its 52-week high vs AMODW's 15.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.94x | 1.78x | 3.09x | 2.18x | 1.55x |
| 52-Week HighHighest price in past year | $0.18 | $2.15 | $18.78 | $16.39 | $417.86 |
| 52-Week LowLowest price in past year | $0.02 | $0.63 | $5.43 | $5.31 | $159.64 |
| % of 52W HighCurrent price vs 52-week peak | +15.1% | +29.6% | +55.2% | +48.0% | +40.3% |
| RSI (14)Momentum oscillator 0–100 | 36.3 | 37.8 | 38.1 | 66.5 | 37.3 |
| Avg Volume (50D)Average daily shares traded | 7K | 1.0M | 15.8M | 195K | 1.7M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: RCAT as "Buy", AVAV as "Buy". Consensus price targets imply 104.2% upside for AVAV (target: $344) vs 63.9% for RCAT (target: $17).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | — | $17.00 | — | $343.60 |
| # AnalystsCovering analysts | — | — | 2 | — | 28 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | 1 | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
AEYE leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). AVAV leads in 1 (Profitability & Efficiency). 1 tied.
AMODW vs PRZO vs RCAT vs AEYE vs AVAV: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AMODW or PRZO or RCAT or AEYE or AVAV a better buy right now?
For growth investors, Red Cat Holdings, Inc.
(RCAT) is the stronger pick with 459. 8% revenue growth year-over-year, versus 14. 5% for AeroVironment, Inc. (AVAV). Alpha Modus Holdings, Inc. (AMODW) offers the better valuation at 0. 2x trailing P/E, making it the more compelling value choice. Analysts rate Red Cat Holdings, Inc. (RCAT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMODW or PRZO or RCAT or AEYE or AVAV?
On trailing P/E, Alpha Modus Holdings, Inc.
(AMODW) is the cheapest at 0. 2x versus AeroVironment, Inc. at 108. 6x. On forward P/E, AeroVironment, Inc. is actually cheaper at 58. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AMODW or PRZO or RCAT or AEYE or AVAV?
Over the past 5 years, Red Cat Holdings, Inc.
(RCAT) delivered a total return of +168. 7%, compared to -82. 3% for ParaZero Technologies Ltd. (PRZO). Over 10 years, the gap is even starker: AVAV returned +498. 7% versus RCAT's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMODW or PRZO or RCAT or AEYE or AVAV?
By beta (market sensitivity over 5 years), AeroVironment, Inc.
(AVAV) is the lower-risk stock at 1. 55β versus Red Cat Holdings, Inc. 's 3. 09β — meaning RCAT is approximately 100% more volatile than AVAV relative to the S&P 500. On balance sheet safety, AeroVironment, Inc. (AVAV) carries a lower debt/equity ratio of 7% versus 15% for AudioEye, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AMODW or PRZO or RCAT or AEYE or AVAV?
By revenue growth (latest reported year), Red Cat Holdings, Inc.
(RCAT) is pulling ahead at 459. 8% versus 14. 5% for AeroVironment, Inc. (AVAV). On earnings-per-share growth, the picture is similar: Alpha Modus Holdings, Inc. grew EPS 917. 6% year-over-year, compared to -28. 9% for AeroVironment, Inc.. Over a 3-year CAGR, RCAT leads at 106. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMODW or PRZO or RCAT or AEYE or AVAV?
AeroVironment, Inc.
(AVAV) is the more profitable company, earning 5. 3% net margin versus -1185. 9% for ParaZero Technologies Ltd. — meaning it keeps 5. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVAV leads at 5. 0% versus -597. 1% for PRZO. At the gross margin level — before operating expenses — AEYE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMODW or PRZO or RCAT or AEYE or AVAV more undervalued right now?
On forward earnings alone, AeroVironment, Inc.
(AVAV) trades at 58. 4x forward P/E versus 94. 3x for Red Cat Holdings, Inc. — 35. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVAV: 104. 2% to $343. 60.
08Which pays a better dividend — AMODW or PRZO or RCAT or AEYE or AVAV?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is AMODW or PRZO or RCAT or AEYE or AVAV better for a retirement portfolio?
For long-horizon retirement investors, AeroVironment, Inc.
(AVAV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+498. 7% 10Y return). Red Cat Holdings, Inc. (RCAT) carries a higher beta of 3. 09 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AVAV: +498. 7%, RCAT: -97. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMODW and PRZO and RCAT and AEYE and AVAV?
These companies operate in different sectors (AMODW (Technology) and PRZO (Industrials) and RCAT (Technology) and AEYE (Technology) and AVAV (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AMODW is a small-cap deep-value stock; PRZO is a small-cap high-growth stock; RCAT is a small-cap high-growth stock; AEYE is a small-cap quality compounder stock; AVAV is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.